https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2022-08-24 / Pharmaceutics 2022 Aug;14(9)
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2022-08-24 / Pharmaceutics 2022 Aug;14(9)2022-08-24 00:00:002022-08-24 00:00:00Immunogenic Cell Death Enhances Immunotherapy of Diffuse Intrinsic Pontine Glioma: From Preclinical to Clinical Studies
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2022-07-22 / Front Mol Biosci 2022;9:816510
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2022-07-22 / Front Mol Biosci 2022;9:8165102022-07-22 00:00:002023-03-07 13:25:25Glucose Deprivation Induced by Acarbose and Oncolytic Newcastle Disease Virus Promote Metabolic Oxidative Stress and Cell Death in a Breast Cancer Model
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2022-07-07 / Cancer Res Commun 2022 Jul;2(7):602-615
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2022-07-07 / Cancer Res Commun 2022 Jul;2(7):602-6152022-07-07 00:00:002022-07-07 00:00:00Avian Paramyxovirus 4 Antitumor Activity Leads to Complete Remissions and Long-term Protective Memory in Preclinical Melanoma and Colon Carcinoma Models
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2022-07-04 / Front Mol Biosci 2022;9:889403
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2022-07-04 / Front Mol Biosci 2022;9:8894032022-07-04 00:00:002022-07-04 00:00:00Development of Molecular Mechanisms and Their Application on Oncolytic Newcastle Disease Virus in Cancer Therapy
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2022-04-05 / PLoS One 2022;17(4):e0264896
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2022-04-05 / PLoS One 2022;17(4):e02648962022-04-05 00:00:002022-04-05 00:00:00Newcastle disease virus expressing an angiogenic inhibitor exerts an enhanced therapeutic efficacy in colon cancer model
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2022-02-28 / Biomedicines 2022 Feb;10(3)
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2022-02-28 / Biomedicines 2022 Feb;10(3)2022-02-28 00:00:002023-01-31 13:07:22Molecular Mechanisms of Anti-Neoplastic and Immune Stimulatory Properties of Oncolytic Newcastle Disease Virus
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2022-02-16 / Genes Immun 2022 Feb;
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2022-02-16 / Genes Immun 2022 Feb;2022-02-16 00:00:002022-02-21 07:49:56Synergy between TMZ and individualized multimodal immunotherapy to improve overall survival of IDH1 wild-type MGMT promoter-unmethylated GBM patients
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2022-01-19 / Genes Immun 2022 02;23(1):1-11
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2022-01-19 / Genes Immun 2022 02;23(1):1-112022-01-19 00:00:002022-01-19 00:00:00Immunogenic cell death and its therapeutic or prognostic potential in high-grade glioma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2021-12-16 / Genes Dis 2023 Mar;10(2):430-446
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2021-12-16 / Genes Dis 2023 Mar;10(2):430-4462021-12-16 00:00:002021-12-16 00:00:00Oncolytic viruses: A novel treatment strategy for breast cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2021-11-19 / J Clin Transl Hepatol 2022 Apr;10(2):284-296
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2021-11-19 / J Clin Transl Hepatol 2022 Apr;10(2):284-2962021-11-19 00:00:002021-11-19 00:00:00Oncolytic Activity of Wild-type Newcastle Disease Virus HK84 Against Hepatocellular Carcinoma Associated with Activation of Type I Interferon Signaling
